| Trial ID: | L3178 |
| Source ID: | NCT02280174
|
| Associated Drug: |
Linagliptin
|
| Title: |
Effect of Linagliptin on TRL Metabolism
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: linagliptin
|
| Outcome Measures: |
Primary: Measurement of the Area Under the Curve of Plasma apoB-48 Levels During Postprandial Period (Time 0,2,4,6,8 Hours), At the end of the 12-week interventions |
|
| Sponsor/Collaborators: |
Sponsor: Ministry of Public Health, Argentina | Collaborators: Aix Marseille UniversitĂ©|Instituto de BiologĂa y Medicina Experimental, IBYME, Buenos Aires, Argentina
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2014-09
|
| Completion Date: |
2016-10
|
| Results First Posted: |
|
| Last Update Posted: |
2014-11-04
|
| Locations: |
National University of Formosa, Formosa, 3600, Argentina
|
| URL: |
https://clinicaltrials.gov/show/NCT02280174
|
